Zepbound Became More Affordable
Eli Lilly cuts Zepbound price to widen access for obesity drug (source Reuters.com) Dec 1 (Reuters) – Eli Lilly (LLY.N), opens new tab said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for weight-loss therapies surges.Patients […]
Zepbound Became More Affordable Read More »


